Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Incyte Corp (INCY) AI Forecast

Our AI detected a significant signal for Incyte Corp. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$INCY Bullish Signal Full forecast available
Sign Up Free

Incyte Corp (INCY) Stock Forecast 2025

Incyte Corp (INCY) AI Stock Price Forecast & Investment Analysis

Incyte Corp Stock Price Chart and Technical Analysis

Loading chart...

Incyte Corp (INCY) - Comprehensive Stock Analysis & Investment Research

Deep dive into Incyte Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 11, 2026, 11:25 p.m. (UTC)

Incyte Corp Investment Summary

When evaluating whether Incyte Corp (INCY) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Incyte Corp (INCY) operates within the Industrial Applications and Services sector, specifically in the Services-Commercial Physical & Biological Research industry. The company employs approximately 2,600 people. With a market capitalization of $19 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Incyte Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Incyte Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Incyte Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Incyte Corp

Sign Up Free
Corporate Identity

Incyte Corp (Stock Symbol: INCY) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Commercial Physical & Biological Research industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Incyte Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Incyte Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Incyte Corp...

Unlock Full Company Profile

Get complete details about Incyte Corp

Sign Up Free
Revenue & Growth Analysis

Incyte Corp generates annual revenues of $5 billion , indicating a well-established business with proven market demand.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Incyte Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Incyte Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Incyte Corp...

Unlock Financial Analysis

Get complete financial metrics for Incyte Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Incyte Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Incyte Corp strategically competes in the highly dynamic Services-Commercial Physical & Biological Research marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Incyte Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company shows positive operational efficiency through free cash flow generation of $609 million annually , with year-over-year cash flow growth of 111.4%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.

Asset Utilization Efficiency

Asset turnover ratio of 0.71x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 3.71 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Incyte Corp (INCY) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Incyte Corp stock analysis.

Deep dive into Incyte Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Incyte Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Incyte Corp: With a P/E ratio of 14.81, the market sees the stock as potentially undervalued.

P/E Ratio 14.81x
P/B Ratio 3.69x
Market Cap $19.06B
EPS $4.31
Book Value/Share $26.04
Revenue/Share $25.91
FCF/Share $-1.22
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Incyte Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Incyte Corp: An ROE of 28.3% demonstrates excellent shareholder value creation.

ROE 28.3%
ROA 21.4%
ROIC 28.0%
Operating Margin -49.5%
Net Margin -82.9%
EBT Margin 18.4%
Tax Rate 13.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Incyte Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Incyte Corp: A current ratio of 3.71 indicates strong liquidity.

Current Ratio 3.71x
Quick Ratio 3.51x
D/E Ratio 0.01x
Financial Leverage 1.31x
Interest Coverage 257.5x
Working Capital $1.73B
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Incyte Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Incyte Corp: Free cash flow of $609M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $759M
Free Cash Flow $609M
Capital Spending -$150M
OCF Growth YoY 111.4%
FCF Growth YoY 140.8%
FCF/Sales 19.6%
CapEx/Sales 4.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Incyte Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Incyte Corp: An asset turnover of 0.71x suggests room for improvement in asset utilization.

Asset Turnover 0.71x
Receivables Turnover 6.5x
Inventory Turnover 6.3x
Fixed Assets Turnover 4.5x
Days Sales Outstanding 56 days
Days Inventory 58 days
Payables Period 264 days
Cash Conversion Cycle -150 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Incyte Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Incyte Corp: With annual revenue of $5141M, Incyte Corp operates at significant scale.

Income Statement
Total Revenue $5.14B
Operating Income -$63M
Net Income -$106M
R&D Expense $145M
SG&A Expense $26M
Cost of Goods Sold $38M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 65%
Cash & Short-term Investments 50%
Total Liabilities 24%
Short-term Debt 1%
Accounts Receivable 11%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 198M
Growth Metrics (YoY)
EPS Growth -0.9%

Latest Incyte Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Incyte Corp (INCY) stock price and investment outlook.

source: Barron's

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More

Incyte Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Incyte Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Absci Corp ABSI ██% $368M -4.7x 1.8x
Bioaffinity Technologies, Inc. BIAF ██% $5M -1.1x 0.6x
Weed, Inc. BUDZ ██% $3M x 397.8x
Cannabis Bioscience International Holdings, Inc. CBIH ██% $5M x 0.1x
Charles River Laboratories International, Inc. CRL ██% $8.78B 19.3x 2.8x
Foxo Technologies Inc. FOXO ██% $310K x x
Icon Plc ICLR ██% $8.14B 8.7x 0.9x
Incyte Corp INCY ██% $19.06B 14.8x 3.7x
Iqvia Holdings Inc. IQV ██% $28.99B 21.3x 4.5x
Ispecimen Inc. ISPC ██% $2M -2.2x 0.8x
Medpace Holdings, Inc. MEDP ██% $13.35B 29.6x 29.1x
Maxcyte, Inc. MXCT ██% $84M -10.6x 0.5x
Inotiv, Inc. NOTV ██% $15M -1.3x 0.1x
National Research Corp NRC ██% $368M 31.8x 26.3x
Omniab, Inc. OABI ██% $283M -6.5x 1.1x
Optimus Healthcare Services, Inc. OHCS ██% $50K x x
Onemednet Corp ONMD ██% $34M 99.7x -1.1x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Incyte Corp Stock Forecast

How accurate are Incyte Corp stock predictions?

Our AI model shows a 3% Spearman correlation coefficient for INCY predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Incyte Corp stock price forecasts?

Our analysis considers Incyte Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Incyte Corp a good investment in 2025?

Based on our AI analysis, Incyte Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Incyte Corp forecasts updated?

Incyte Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...